HI SB226 | 2025 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on January 15 2025 - 25% progression
Action: 2025-01-17 - Referred to HHS, CPN.
Pending: Senate Health and Human Services Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 15 2025 - 25% progression
Action: 2025-01-17 - Referred to HHS, CPN.
Pending: Senate Health and Human Services Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Establishes requirements for the clinical review criteria and clinical practical guidelines used to establish step therapy protocols. Provides a process for a patient to request an exception to using step therapy protocols. Establishes insurance coverage requirements relating to the use of step therapy protocols and standards to appeal an adverse step therapy exception determination.
Title
Relating To Prescription Drugs.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2025-01-17 | Senate | Referred to HHS, CPN. |
2025-01-15 | Senate | Introduced and passed First Reading. |
2025-01-13 | Senate | Pending Introduction. |
Same As/Similar To
HB216 (Same As) 2025-01-21 - Referred to HLT, CPC, FIN, referral sheet 1
Subjects
Clinical Practice Guidelines
Clinical Review Criteria
Exceptions
Health Insurance
Prescription Drugs
Step Therapy Protocol
Clinical Review Criteria
Exceptions
Health Insurance
Prescription Drugs
Step Therapy Protocol
Hawaii State Sources
Type | Source |
---|---|
Summary | https://www.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=SB&billnumber=226&year=2025 |
Text | https://www.capitol.hawaii.gov/sessions/session2025/bills/SB226_.HTM |